Hakan M Usal, MD | |
305 Route 17 South Unit 3-100a, Paramus, NJ 07652 | |
(201) 967-9200 | |
(201) 967-8300 |
Full Name | Hakan M Usal |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 38 Years |
Location | 305 Route 17 South Unit 3-100a, Paramus, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396732954 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Plastic Surgery Center | 8921060484 | 60 |
News Archive
The next five years of HIV research should shift gears from the classic single-therapy development model to moving directly from in vitro studies to combination therapy trials, authors argue in a new paper published online today.
In a research paper recently uploaded to the preprint server bioRxiv* by Gecht et al. (August 4th, 2021), a new method of representing glycan conformers on static protein structures is explored, named GlycoSHIELD.
News outlets are reporting that some observers view the step an "embarrassing episode" for the administration and note that some of the rule's supporters consider it a "flip flop." All in all, the rule change and the reaction to it appear to highlight the continued politics that surround the issue.
Researchers provide an overview of SARS-CoV-2 and its life cycle pathways, addressing the functional changes in the viral proteins, providing important strategic clues to help that may help in the ongoing development of therapies against COVID-19.
› Verified 7 days ago
Entity Name | The Plastic Surgery Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386613834 PECOS PAC ID: 8921060484 Enrollment ID: O20041028000139 |
News Archive
The next five years of HIV research should shift gears from the classic single-therapy development model to moving directly from in vitro studies to combination therapy trials, authors argue in a new paper published online today.
In a research paper recently uploaded to the preprint server bioRxiv* by Gecht et al. (August 4th, 2021), a new method of representing glycan conformers on static protein structures is explored, named GlycoSHIELD.
News outlets are reporting that some observers view the step an "embarrassing episode" for the administration and note that some of the rule's supporters consider it a "flip flop." All in all, the rule change and the reaction to it appear to highlight the continued politics that surround the issue.
Researchers provide an overview of SARS-CoV-2 and its life cycle pathways, addressing the functional changes in the viral proteins, providing important strategic clues to help that may help in the ongoing development of therapies against COVID-19.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Hakan M Usal, MD 535 Sycamore Ave, Shrewsbury, NJ 07702-4224 Ph: (732) 333-8720 | Hakan M Usal, MD 305 Route 17 South Unit 3-100a, Paramus, NJ 07652 Ph: (201) 967-9200 |
News Archive
The next five years of HIV research should shift gears from the classic single-therapy development model to moving directly from in vitro studies to combination therapy trials, authors argue in a new paper published online today.
In a research paper recently uploaded to the preprint server bioRxiv* by Gecht et al. (August 4th, 2021), a new method of representing glycan conformers on static protein structures is explored, named GlycoSHIELD.
News outlets are reporting that some observers view the step an "embarrassing episode" for the administration and note that some of the rule's supporters consider it a "flip flop." All in all, the rule change and the reaction to it appear to highlight the continued politics that surround the issue.
Researchers provide an overview of SARS-CoV-2 and its life cycle pathways, addressing the functional changes in the viral proteins, providing important strategic clues to help that may help in the ongoing development of therapies against COVID-19.
› Verified 7 days ago
Dr. John Michael Danks, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 W Ridgewood Ave Ste 106, Paramus, NJ 07652 Phone: 201-389-3700 Fax: 201-389-6191 | |
Dr. Tzvi Small, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 275 Forest Ave, Suite 202, Paramus, NJ 07652 Phone: 201-599-1500 Fax: 201-599-1501 | |
Dr. Hans J Schmidt, M.D Surgery Medicare: Accepting Medicare Assignments Practice Location: 81 E State Rt 4, 35 Plaza Professional Certer, Suite 401, Paramus, NJ 07652 Phone: 201-646-1121 Fax: 201-646-1110 | |
Dr. Andrea S Bedrosian, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 81 E Rte 4, 35 Plaza Building Suite 401, Paramus, NJ 07652 Phone: 201-646-1121 Fax: 201-646-1110 | |
Dr. Nebil Bill Aydin, MD Surgery Medicare: Medicare Enrolled Practice Location: 140 N Rte 17, Suite 200, Paramus, NJ 07652 Phone: 201-345-0100 Fax: 201-820-0333 | |
Rajinder P Gandhi, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 30 W Century Rd, Suite 235, Paramus, NJ 07652 Phone: 201-225-9440 Fax: 201-225-9430 | |
Dr. Douglas R Ewing, M.D Surgery Medicare: Accepting Medicare Assignments Practice Location: 81 E State Rt 4, 35 Plaza Professional Center, Suite 401, Paramus, NJ 07652 Phone: 201-646-1121 Fax: 201-646-1110 |